SOPHiA GENETICS to Present at the J.P. Morgan 2023 Healthcare Conference

Jan 4 2023
BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Jan. 4, 2023-- SOPHiA GENETICS SA (NASDAQ: SOPH) today announced that Dr. Jurgi Camblong, Chief Executive Officer and Co-Founder, is scheduled to present at the J.P. Morgan 2023 Healthcare Conference on Tuesday, January 10, 2023 , at 8:15 a.m.

Read more

Build something bigger than your career

Enjoyed learning about life at SOPHiA from our blogs? Here are a few of our open roles

Title Country Department
Regional Field Marketing Manager - APAC Australia. Singapore Marketing & Communications
Junior Algorithm Developer Intern Switzerland Data Science
Junior Information Security Analyst Intern France Regulatory & Quality
Sales Executive / Senior Sales Executive United Kingdom Clinical Sales
Strategic Account Manager - JAPAN Japan Clinical Sales